Skip to search formSkip to main contentSkip to account menu

bosutinib 500 MG Oral Tablet [Bosulif]

Known as: BOSUTINIB MONOHYDRATE 500 mg ORAL TABLET, FILM COATED [BOSULIF], Bosulif 500 MG (bosutinib monohydrate 516.98 MG) Oral Tablet, Bosulif 500 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

14 relations
BosulifBosutinib monohydrateCroscarmellose SodiumMagnesium stearate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Bosutinib (▼ BOSULIF®): Leucemia mieloide crónica
Review
2016
Review
2016
[Pharmacology profile and clinical findings of bosutinib hydrate (Bosulif® Tablets)].
要約:慢性骨髄性白血病(CML)患者の 95%以上で発 現している Bcr-Abl融合遺伝子は,その恒常的な活性 化が白血病細胞の増殖に関与しており,Bcr-Ablチロ シンキナーゼは CML… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)